Borderline Ovarian Tumors and Diagnostic Dilemma of Intraoperative Diagnosis: Could Preoperative He4 Assay and ROMA Score Assessment Increase the Frozen Section Accuracy? A Multicenter Case-Control Study

The aim of our study was to assess the value of a preoperative He4-serum-assay and ROMA-score assessment in improving the accuracy of frozen section histology in the diagnosis of borderline ovarian tumors (BOT). 113 women presenting with a unilateral ovarian mass diagnosed as serous/mucinous BOT at frozen-section-histology (FS) and/or confirmed on final pathology were recruited. Pathologists were informed of the results of preoperative clinical/instrumental assessment of all patients. For Group_A patients, additional information regarding He4, CA125, and ROMA score was available (in Group_B only CA125 was known). The comparison between Group A and Group B in terms of FS accuracy, demonstrated a consensual diagnosis in 62.8% versus 58.6% (P: n.s.), underdiagnosis in 25.6% versus 41.4% (P < 0.05), and overdiagnosis in 11.6% versus 0% (P < 0.01). Low FS diagnostic accuracy was associated with menopausal status (OR: 2.13), laparoscopic approach (OR: 2.18), mucinous histotype (OR: 2.23), low grading (OR: 1.30), and FIGO stage I (OR: 2.53). Ultrasound detection of papillae (OR: 0.29), septa (OR: 0.39), atypical vascularization (OR: 0.34), serum He4 assay (OR: 0.39), and ROMA score assessment (OR: 0.44) decreased the probability of underdiagnosis. A combined preoperative assessment through serum markers and ultrasonographic features may potentially reduce the risk of underdiagnosis of BOTs on FS while likely increasing the concomitant incidence of false-positive events.

• Publication year

  2014

• Venue

  BioMed Research International

• Publication date

  2014-11-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2014/803598PMID 25431767PMCID 4238177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intra‐ and interobserver agreement with regard to describing adnexal masses using International Ovarian Tumor Analysis terminology: reproducibility study involving seven observers

  2014cited by this paper
• Validity of intraoperative diagnosis at laparoscopic surgery for ovarian tumors.

  2014influential reference
• The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging

  2014cited by this paper
• Staging classification for cancer of the ovary, fallopian tube, and peritoneum

  2014cited by this paper
• HE4 tissue expression in borderline ovarian tumors: a pilot study by the tumorbank ovarian cancer network.

  2013cited by this paper
• Fertility Preservation in Young Women With Cervical Cancer: An Oncologic Dilemma or a New Conception of Fertility Sparing Surgery?

  2013cited by this paper
• Could kidney glomerular filtration impairment represent the “Achilles heel” of HE4 serum marker? A possible further implication

  2013cited by this paper
• Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome.

  2013cited by this paper
• Staging classification for cancer of the ovary, fallopian tube, and peritoneum☆

  2013influential reference
• Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence.

  2012cited by this paper
• HE4 in gynecological cancers: report of a European investigators and experts meeting

  2012cited by this paper
• The value of frozen section evaluation in the management of borderline ovarian tumors.

  2011influential reference
• Risk factors for recurrence of ovarian borderline tumors.

  2011cited by this paper
• Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.

  2011cited by this paper
• HE4 in ovarian cancer: from discovery to clinical application.

  2011cited by this paper
• Accuracy of frozen section diagnosis of borderline ovarian tumors.

  2011cited by this paper
• CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate.

  2011cited by this paper
• Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group

  2010cited by this paper
• Role of D-dimer testing in severe pelvic inflammatory disease: a new usable marker to assess the need for fertility-impairing surgery?

  2010cited by this paper
• Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary.

  2009cited by this paper
• Accuracy of frozen section diagnosis in ovarian masses: experience at a tertiary oncology center

  2009cited by this paper
• Incidence of port-site metastasis after laparoscopic management of borderline ovarian tumors: a series of 22 patients.

  2009cited by this paper
• Accuracy of intraoperative frozen section in the diagnosis of ovarian tumors

  2008influential reference
• The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

  2008cited by this paper
• Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors.

  2008cited by this paper
• Surgical staging, treatment, and follow‐up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland

  2007cited by this paper
• The role of frozen section evaluation in the diagnosis of adnexal mass

  2007cited by this paper
• Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature.

  2007cited by this paper
• Management of borderline ovarian tumors: results of an Italian multicenter study.

  2006cited by this paper
• The accuracy of frozen section (intraoperative consultation) in the diagnosis of ovarian masses.

  2005cited by this paper
• Diagnostic accuracy of frozen section diagnosis of the adnexal mass: a metaanalysis.

  2005cited by this paper
• Frozen section in laparoscopic management of macroscopically suspicious ovarian masses.

  2004cited by this paper
• Long-term survival and patterns of care in women with ovarian tumors of low malignant potential.

  2002cited by this paper
• Borderline Tumors of the Ovary: Correlation of Frozen and Permanent Histopathologic Diagnosis

  2000cited by this paper
• Laparoscopic management of organic ovarian cysts: is there a place for frozen section diagnosis?

  1998cited by this paper
• Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior

  1973cited by this paper
• Atlas of tumor pathology

  1954cited by this paper
• Atlas of Tumor Pathology

  1954cited by this paper

• Scope and limitations of intraoperative cytological methods of diagnosis of ovarian tumors

  2025cites this paper
• Do Exophytic and Endophytic Patterns in Borderline Ovarian Tumors Have Different Prognostic Implications? A Large Multicentric Experience

  2023cites this paper
• EPCAM+CD45+ cells in ascitic fluid of patients with ovarian cancer: a relationship with tumor marker levels and tumor grade

  2022cites this paper
• Predictive features of borderline ovarian tumor recurrence in patients with childbearing potential undergoing conservative treatment.

  2022cites this paper
• Comparing the Diagnostic Value of the Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in Women with an Adnexal Mass

  2021cites this paper
• Modified HE4, CA125, and ROMA cut-off values and predicted probability of ovarian tumor in Chinese patients.

  2021cites this paper
• A strengthening the reporting of observational studies in epidemiology (STROBE)

  2021cites this paper
• [Borderline ovarian tumours: CNGOF Guidelines for clinical practice - Value of tumor markers].

  2020cites this paper
• Frozen Section as a Guide in Intraoperative Decision-making in the Management of Adnexal Mass Lesions

  2020cites this paper
• Clinical implementation of novel diagnostic biomarkers for epithelial ovarian cancer - Can we improve diagnosis?

  2020cites this paper
• Are HE4 and CA 125 suitable to detect a Paget disease of the vulva?

  2020cites this paper
• Nouvelles recommandations pour le bilan des masses annexielles indéterminées

  2020cites this paper
• Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial

  2019cites this paper
• Clinical Features and Management of Women with Borderline Ovarian Tumors in a Single Center in Brazil

  2019cites this paper
• Factors affecting compliance of intraoperative frozen and final histopathology in borderline ovarian tumors: Retrospective cohort study

  2019cites this paper
• CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages

  2019cites this paper
• Borderline ovarian neoplasms

  2019cites this paper
• A Comparative Study of RMI and ROMA in Women Presenting with an Adnexal Mass

  2018cites this paper
• Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis.

  2018cites this paper
• Discriminative value of CA-125, HE4, Risk of Malignancy Index II (RMI-II) and Risk of Malignancy Algorithm (ROMA) in the differential diagnosis of pelvic masses: conclusions from a referral Centre in Portugal

  2018cites this paper
• Frozen section as a guide in intra operative decision making in management of adnexal mass lesions

  2018cites this paper
• A novel hysteroscopic approach for ovarian cancer screening/early diagnosis.

  2017cites this paper
• HE4-test of urine and body fluids for diagnosis of gynecologic cancer

  2017cites this paper
• The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor.

  2016cites this paper
• Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies

  2016cites this paper
• Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125

  2016cites this paper
• Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience

  2016cites this paper